From the viewpoint of the laboratory findings, patients with HCC development or recurrence after SVR were characterized by lower platelet counts (<80,000/μL), low albumin levels (<3.9 g/dL), and elevated AFP levels (>3.3 ng/mL) on post-SVR blood tests [41]. Here, ALB is linked to hepatocellular carcinoma.